UnitedHealth Group (NYSE:UNH) Updates FY25 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY25 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $29.50-30.00 for the period, compared to the consensus estimate of $29.83. The company issued revenue guidance of $450-455 billion, compared to the consensus revenue estimate of $447.90 billion.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $510.03 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a 50 day moving average of $551.50 and a 200-day moving average of $562.62. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market capitalization of $469.37 billion, a P/E ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 EPS. The firm’s revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

UNH has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.